Advertisement
U.S. Markets closed

Omega Therapeutics, Inc. (OMGA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.0700+0.0100 (+0.94%)
At close: 04:00PM EDT
1.0700 0.00 (0.00%)
After hours: 05:22PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.0600
Open1.0800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.0400 - 1.0800
52 Week Range0.8900 - 6.3000
Volume116,056
Avg. Volume200,251
Market Cap59.016M
Beta (5Y Monthly)1.84
PE Ratio (TTM)N/A
EPS (TTM)-1.4200
Earnings DateAug 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.14
  • GlobeNewswire

    Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

    CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it will share new preclinical data at three upcoming scientific meetings. “These preclinical results build upon the foundation of data we have shared to date and expand our confidence in the ability of epigenomic controllers to upregulate or downregulate th

  • PR Newswire

    Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors

    Invaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, today announced the appointment of André Andonian as the new Chairman of its Board of Directors. Robert Berendes has decided to step down after serving as Chairman of the Board since 2019 and will continue to serve on the board of Invaio.